Sign in
8-K

Current Report

Apimeds Pharmaceuticals US, Inc. Filed Acc 0001213900-26-092680

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading ea0303076-8k_apimeds.htm…